IP Verse

Schiener patent opposition analysis

The comprehensive analysis of Schiener opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Schiener

Stay updated with the latest patent oppositions filed by Schiener

Patent NumberTitleApplicantOpposition DateOpposition Company
EP2598119
Preservative Free Brimonidine And Timolol SolutionsALLERGANJun 18, 2019WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIG
EP2598118
Preservative Free Bimatoprost And Timolol SolutionsALLERGANJun 4, 2019WCHTERSHUSER & HARTZ
EP2490986
Methods And Systems For Purifying Non-Complexed Botulinum NeurotoxinREVANCE THERAPEUTICSMay 2, 2019WCHTERSHUSER & HARTZ
EP2578228
Non-Diffusive Botulinum Toxin Causing Local Muscle Paralysis, And Purification Method ThereofMEDEXGENAug 14, 2018WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIG
EP2269604
Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISApr 27, 2017TEVA PHARMACEUTICAL INDUSTRIES LTD
EP1396254
Prepolymerized Filler In Dental Restorative CompositeKERRJun 2, 2016RPE
EP1574215
Solid Drug For Oral UseKISSEI PHARMACEUTICALApr 14, 2016TEVA PHARMACEUTICAL INDUSTRIES LTD
EP2058326
Method For The Purificaiton Of G-CsfSANDOZApr 8, 2016GENERICS UK
EP2269603
Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISFeb 22, 2016ACTAVIS PTC EHF
EP2269603
Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISFeb 18, 2016TEVA PHARMACEUTICALS INC.

Top clients of Schiener

Top companies who are the clients of Schiener

CompanyTotal
WCHTERSHUSER & HARTZ4
TEVA PHARMACEUTICAL INDUSTRIES LTD2
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB2
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIG2
ACTAVIS PTC EHF1
GENERICS UK1
TEVA PHARMACEUTICALS INC.1
RPE1